Biotech

All Articles

James Wilson leaving behind Penn to release 2 new biotechs

.After much more than 30 years, gene treatment trailblazer James Wilson M.D., Ph.D., is actually lea...

3 biotechs try to trump the summer season warmth by dropping team

.As biotechs try to switch a new page in August, at the very least three firms have lost workers in ...

venBio lifts $528M for 5th lifestyle sciences VC fund

.Professional venture capital agency venBio has elevated another half a billion bucks to invest in b...

Otsuka pays for $800M for Jnana as well as its own clinical-stage PKU drug

.Otsuka Drug has actually picked up Boston-based Jnana Therapeutics for $800 thousand so the Orienta...

FibroGen lays off 75% of US workers as property flunks 2 even more tests

.FibroGen is substantially reorganizing its own company, giving up 75% of its U.S. personnel as well...

Tracon winds down weeks after injectable PD-L1 inhibitor stop working

.Tracon Pharmaceuticals has actually decided to wane procedures full weeks after an injectable immun...

Ideaya bags choice on Biocytogen bispecific ADC in $400M offer

.Ideaya Biosciences is wagering $400 thousand in biobucks that a bispecific antibody-drug conjugate ...

Takeda takes $140M loss on neglected epilepsy medicine, promotes FDA run

.Our experts actually recognize that Takeda is wanting to locate a path to the FDA for epilepsy medi...

VBI Vaccines apply for insolvency, seeks asset purchase

.Immunology biotech VBI Vaccines is drifting alarmingly near the defining moment, along with plans t...

Celldex anti-cKIT antitoxin reduce colonies in one more phase 2 research

.It is actually challenging to muscle mass in on a space as very competitive as immunology, yet Cell...